GNOM : Global X Genomics & Biotechnology ETF

GNOM is a Sector Equity Market Healthcare with MODERATE fees.

GNOM

Global X Genomics & Biotechnology ETF

FI Score

43 /100

Diversification Rating

10 /10

Expense Ratio Rating

7 /10

Expense Rating

3 /10

Market Score

1 /10

Category Score

0 /10

Market Size

1 /10

43% FI Score
  • gnom
  • ETF
  • Sector Equity
  • Healthcare

Global X Genomics & Biotechnology ETF

Expenses: 0.68% (Better than 1% of similar funds)

This is a bad choice for a Healthcare Sector Equity fund. See why ยป

Fund Summary

The investment seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Solactive Genomics Index (underlying index). The fund invests at least 80% of its total assets in the securities of the underlying index. The underlying index is designed to provide exposure to exchange-listed companies that are positioned to benefit from further advances in the field of genomic science and biotechnology, as well as applications thereof (collectively, Genomics & Biotechnology Companies), as defined by Solactive AG, the provider of the underlying index. The fund is non-diversified.

Largest Holdings

Amount Holding
4.68% Sarepta Therapeutics, Inc
4.33% CRISPR Therapeutics AG
4.27% Natera, Inc
4.12% Agilent Technologies, Inc
4.09% Illumina, Inc
4.07% Allogene Therapeutics, Inc
4.05% BioMarin Pharmaceutical Inc
4.02% bluebird bio, Inc
3.72% Ultragenyx Pharmaceutical Inc
3.68% uniQure N.V

Minafi - The intersection of FI, minimalism & mindfulness.

Don't miss out on new posts, courses, interactive articles and more!

Join & Get Your First Course Free

© 2024   Adam Fortuna

Site Map
Triangle Graduation Cap Angle Down Book regular Phone laptop regular fire regular fire regular search regular Acorn duotone Seedling duotone thumbs down duo thumbs up duo